AASLD: American Association for the Study of Liver Diseases
Your network for the investigation and treatment of liver diseases About Us | Log In/Out | Member Center
 
Education and Training

AASLD/AGA Institute GastroSlides Unit on Liver Cancer 
|

 

AASLD/AGA Institute GastroSlides (38 MB, 264 pages)

AASLD/AGA Institute GastroSlides (40 MB, 264 slides)

The AASLD/AGA Institute GastroSlides Unit on Liver Cancer is intended to represent a new set of 250 images that illustrate epidemiological trends, causes, pathogenesis, screening, diagnosis and management of liver cancer, primarily hepatocellular carcinoma. The outstanding photographs, micrographs, and illustrations explain important concepts in our understanding of the underlying pathophysiology of liver cancer.

Management algorithms for this dire complication of advanced liver disease will aid the clinician in counseling and caring for patients. Images, including graphic representations of data from key studies, are accompanied by explanatory legends that contain recent literature citations, thereby providing a unique teaching and self-educational resource. Clinical cases provide a framework for using the slides for self-education and to teach practicing clinicians, fellows, residents and medical students. The senior author, Hashem B. El-Serag, MD, M.P.H. is Associate Professor of Medicine, Baylor College of Medicine, Houston, TX.

Liver Cancer is separated into the following general sections: Part I: Epidemiology, Part II: Screening, Part III: Diagnosis, Part IV: Pathology, Part V:Pathogenesis, Part VI: Treatment, Part VII: Illustrative Cases.

Goals and Objectives

  • Describe trends in the prevalence and incidence of Hepatocellular Carcinoma (HCC). 
  • Recognize most important risk factors for developing HCC. 
  • Discuss the clinical implications and importance of screening and surveillance strategies in monitoring patient populations at high risk for HCC.
  • Describe HCC staging.
  • Describe current pharmacologic, surgical and transplant treatment options for HCC.
  • Recount recent clinical trial results relevant to the treatment of HCC.
  • Discuss ongoing research in multimodality treatment approaches for HCC.

AASLD/AGA Institute GastroSlides (38 MB, 264 pages)

AASLD/AGA Institute GastroSlides (40 MB, 264 slides)

Author(s)
Senior Author:
Hashem B. El-Serag, MD, MPH.
Associate Professor of Medicine
Baylor College of Medicine
Houston, TX

Co-Authors:
Jorge Marrero, MD
Assistant Professor of Medicine
University of Michigan
Ann Arbor, MI

K. Rajendar Reddy, MD
Professor of Medicine and Surgery
University of Pennsylvania
Philadelphia, PA

Lewis Roberts, MD, PhD
Associate Professor of Medicine
Mayo Clinic College of Medicine
Rochester, MN

Snorri S.Thorgeirsson, MD, PhD
Chief, Laboratory of Experimental Carcinogenesis
Center for Cancer Research
National Cancer Institute, NIH

Artists:
Stan Coffman
Jerry Schoendorf, MAMS
Chapel Hill, NC

The AASLD/AGA Institute GastroSlides Unit on Liver Cancer is sponsored by educational grants from Bayer HealthCare Pharmaceuticals and Onyx Pharmaceuticals.